journal article·2001-01

Fibronectin purification from human plasma in a packed-bed column system with gelatin immobilized PHEMA microspheres

Fatma Kayirhan-Denizli, M. Yakup Arica, Adil Denizli

Publisher page

Abstract

Bioaffinity chromatography has a unique and powerful role that is used as a purification tool in the production of therapeutic plasma protein derivatives. In this study, a bioaffinity-ligand, i.e. gelatin, was covalently immobilized with PHEMA microspheres (150-200 microm in diameter). The affinity sorbent carrying 7.5 mg gelatin g(-1) polymer was then used to separate fibronectin from human plasma in a packed-bed column system. Fibronectin separation from human plasma on unmodified PHEMA microspheres was 0.45 mg g(-1), while much higher adsorption values, up to 21.8 mg g(-1), were obtained with gelatin-immobilized microspheres. The fibronectin adsorption capacity of the microspheres decreased with an increase in the recirculation rate of plasma. Fibronectin adsorption increased with decreasing temperature, and the maximum adsorption achieved at 4 degrees C (26.3 mg fibronectin g(-1)). Up to 94.7% of the adsorbed fibronectin was desorbed by using 2 M urea in the presence of 1 M sodium chloride as elution agent. The adsorption-desorption cycle was repeated ten times using the same affinity column. There was no remarkable reduction in the adsorption capacity of the gelatin-immobilized PHEMA microspheres.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cell Adhesion Molecules Research · Blood properties and coagulation · Platelet Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. Ruoslahti E. · Cell · 1994 · 77 · 47710.1016/0092-8674(94)90209-7 ↗
2. Hynes R. O. · 199010.1007/978-1-4612-3264-3 ↗
3. Regnault V. · J. Chromatogr. · 1988 · 432 · 9310.1016/S0378-4347(00)80636-2 ↗
4. Mosesson M. W. · J. Biol. Chem. · 1970 · 245 · 572810.1016/S0021-9258(18)62713-9 ↗
5. Allain J. P. · Rev. Fr. Transfus. Immunohematol. · 1983 · 26 · 12310.1016/S0338-4535(83)80087-7 ↗
6. Engvall E. · Int. J. Cancer · 1977 · 20 · 110.1002/ijc.2910200102 ↗
7. Agin P. P. · Bioch. Biophys. Acta · 1982 · 716 · 44310.1016/0304-4165(82)90039-3 ↗
8. Stol M. · J. Chromatogr. · 1987 · 419 · 30810.1016/0378-4347(87)80292-X ↗
9. Hebeeb A. F. S. A. · Biochim. Biophys. Acta · 1981 · 673 · 52710.1016/0304-4165(81)90484-0 ↗
10. Ruoslahti E. · Biochim. Biophys. Acta · 1980 · 631 · 35010.1016/0304-4165(80)90308-6 ↗
11. Ruoslahti E. · Methods Enzymol. · 1982 · 82 · 80310.1016/0076-6879(82)82103-4 ↗
12. Denizli A. · J. Chromatogr. B. · 1995 · 666 · 21510.1016/0378-4347(94)00593-T ↗
13. Denizli A. · J. Chromatogr. B. · 1995 · 668 · 1310.1016/0378-4347(95)00047-M ↗
14. Denizli A. · J. Chromatogr. B. · 1995 · 670 · 15710.1016/0378-4347(95)00144-8 ↗
15. Denizli A. · J. Chromatogr. B. · 1998 · 707 · 2510.1016/S0378-4347(97)00612-9 ↗
16. Denizli F. · Polym. Int. · 2000 · 49 · 30210.1002/(SICI)1097-0126(200003)49:3<302::AID-PI366>3.0.CO;2-R ↗
17. Denizli F. · React. Functl. Polym. · 2000 · 44 · 20710.1016/S1381-5148(99)00094-2 ↗
18. 10.1163/15685620074376010.1163/156856200743760 ↗
19. Harlow E. · 1988
20. Tietz, N. W. 1986.Textbook of Clinical Chemistry, 589Philadelphia, PA: W. B. Saunders.
21. Clauss A. · Acta Haemat. · 1957 · 17 · 23710.1159/000205234 ↗
22. Denizli A. · J. Appl. Polym. Sci. · 1999 · 74 · 65510.1002/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N ↗
23. Brash J. L. · 198710.1021/bk-1987-0343 ↗
24. Missirlis Y. F. · 1990
25. Brown E. J. · Mol. Immunol. · 1987 · 24 · 22110.1016/0161-5890(87)90139-8 ↗
26. Müller-Schulte D. · J. Chromatogr. · 1991 · 539 · 30710.1016/S0021-9673(01)83939-X ↗
27. Pharmacia Fine Chemicals · 1982
28. Matejtschuk, P., ed. 1997.Affinity Separations: A Practical Approach, 62Oxford: Oxford University Press.10.1093/oso/9780199635504.001.0001 ↗